Department of Medicine, The MetroHealth System and.
Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio.
J Am Soc Nephrol. 2018 Jan;29(1):81-91. doi: 10.1681/ASN.2017030314. Epub 2017 Oct 9.
Albuminuria and tubular atrophy are among the highest risks for CKD progression to ESRD. A parsimonious mechanism involves leakage of albumin-bound nonesterified fatty acids (NEFAs) across the damaged glomerular filtration barrier and subsequent reabsorption by the downstream proximal tubule, causing lipoapoptosis. We sought to identify the apical proximal tubule transporter that mediates NEFA uptake and cytotoxicity. We observed transporter-mediated uptake of fluorescently labeled NEFA in cultured proximal tubule cells and microperfused rat proximal tubules, with greater uptake from the apical surface than from the basolateral surface. Protein and mRNA expression analyses revealed that kidney proximal tubules express transmembrane fatty acid transporter-2 (FATP2), encoded by , but not the other candidate transporters CD36 and free fatty acid receptor 1. Kidney FATP2 localized exclusively to proximal tubule epithelial cells along the apical but not the basolateral membrane. Treatment of mice with lipidated albumin to induce proteinuria caused a decrease in the proportion of tubular epithelial cells and an increase in the proportion of interstitial space in kidneys from wild-type but not mice. microperfusion and experiments with NEFA-bound albumin at concentrations that mimic apical proximal tubule exposure during glomerular injury revealed significantly reduced NEFA uptake and palmitate-induced apoptosis in microperfused proximal tubules and or FATP2 shRNA-treated proximal tubule cell lines compared with wild-type or scrambled oligonucleotide-treated cells, respectively. We conclude that FATP2 is a major apical proximal tubule NEFA transporter that regulates lipoapoptosis and may be an amenable target for the prevention of CKD progression.
白蛋白尿和肾小管萎缩是慢性肾脏病进展为终末期肾病的最高风险因素之一。一个简单的机制涉及白蛋白结合的非酯化脂肪酸 (NEFA) 穿过受损的肾小球滤过屏障泄漏,随后被下游近端肾小管重吸收,导致脂肪细胞凋亡。我们试图确定介导 NEFA 摄取和细胞毒性的顶端近端肾小管转运体。我们观察到培养的近端肾小管细胞和微灌注的大鼠近端肾小管中荧光标记的 NEFA 的转运体介导摄取,从顶端表面摄取的量大于从基底外侧表面摄取的量。蛋白质和 mRNA 表达分析表明,肾脏近端小管表达跨膜脂肪酸转运蛋白-2 (FATP2),由 编码,但不表达其他候选转运蛋白 CD36 和游离脂肪酸受体 1。肾脏 FATP2 仅定位于近端肾小管上皮细胞的顶端膜,而不是基底外侧膜。用脂质化白蛋白处理小鼠以诱导蛋白尿导致野生型小鼠而非 小鼠的管状上皮细胞比例降低,间质空间比例增加。用 NEFA 结合白蛋白进行 微灌注和 实验,浓度模拟肾小球损伤期间顶端近端小管暴露,与野生型或 scrambled 寡核苷酸处理的细胞相比,微灌注的 近端小管和 或 FATP2 shRNA 处理的近端肾小管细胞系中,NEFA 摄取和棕榈酸诱导的细胞凋亡明显减少。我们得出结论,FATP2 是一种主要的顶端近端肾小管 NEFA 转运体,可调节脂肪细胞凋亡,可能是预防慢性肾脏病进展的可行靶点。